Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2023–2028 · research · R01
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors
Roza Insafetdinovna Nurieva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
Anna Coghill · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
Preclinical studies of non-nucleoside DNMT3A/3B inhibitors
Taiping Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
Di Zhao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Role of NSD3 in regulation of cancer pathogenesis
Or P. Gozani · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · cooperative agreement · U01
Identifying and targeting collateral lethal vulnerabilities in cancers
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Targeting Non-Canonical STING Signaling to Treat SPOP Mutant Castration-Resistant Prostate Cancer
Timothy Charles Thompson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Harnessing Endoplasmic Reticulum Stress to Overcome Resistance to Immunotherapy in Immune-cold Breast Cancer
Xi Chen · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2028 · research · R37
An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma
Rahul Anil Sheth · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer
Katherine Arnold Hutcheson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
Or P. Gozani · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Role of NSD3 in regulation of cancer pathogenesis
Or P. Gozani · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2024 · program · P50
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
Elizabeth J Shpall · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · LCRF Leading Edge Research Grant Program
2023 – LCRF Leading Edge Research Grant Program – University of Texas M.D. Anderson Cancer Center – Benjamin Morris, PhD
Benjamin Morris · The University of Texas MD Anderson Cancer Center · funded by Lung Cancer Research Foundation
2023–2028 · cooperative agreement · U54
Center for Transformative Community-Driven Research to Prevent Obesity-related Cancer
Karen M Basen-Engquist · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
First-in-Human Imaging of Innate Immunity Activation with a Redox-Tuned PET Reporter
David Piwnica-Worms · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Other
Other - University of Texas MD Anderson Cancer Center (2023)
The University of Texas MD Anderson Cancer Center · funded by Conrad N. Hilton Foundation
2023 · grant · Academic Research
A Novel Therapeutic Strategy Targeting Pancreatic Cancer
Wantong Yao · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023 · grant · Prevention
Dissemination of the Active Living After Cancer Program
Karen M Basen-Engquist · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2027 · research · R01
Role of PRMT7 in Genomic Imprinting
Taiping Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Dissecting and targeting tumor-TME crosstalk to forestall acquired KRASG12C inhibitor resistance in NSCLC.
Ferdinandos Skoulidis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Mechanisms of action and therapeutic targeting of the CARM1-NFIB axis in small cell lung cancer
Mark T. Bedford · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
Cullen Mitsuo Taniguchi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
Hypoglossal neuropathy in the pathogenesis of radiation associated dysphagia (hRAD)
Katherine Arnold Hutcheson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Targeting non-small cell lung cancer cells and the adverse tumor microenvironment with a small-molecule STAT3 inhibitor
Seyed Javad Mirhassani Moghaddam · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
A novel combination therapeutic approach to revitalizing immunotherapy for bone metastatic prostate cancer
Sue-Hwa Lin · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2026 · research · R01
Multi-site feasibility and acceptability of a faith-based mind-body intervention in Black adults
Scherezade Kelly Mama · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · fellowship · Fellowship Award
NSF PRFB FY 2022: Uncovering the Influence of Hormone Signaling in Reptile Reproductive Development: Using CRISPR to Link Genotype, Phenotype, and Fitness
Bonnie Kircher · The University of Texas MD Anderson Cancer Center · funded by National Science Foundation
2023–2028 · research · R01
Molecular Mechanisms of Bladder Cancer Immunometabolism
Jianjun Gao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Multi-component Interventions to Improve Uptake and Adherence to Lung Cancer Screening
Robert J Volk · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2025 · cooperative agreement · UH3
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
William F Symmans · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Molecular Mechanisms of Bladder Cancer Immunometabolism
Jianjun Gao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Targeting distinct metabolic vulnerabilities of aggressive renal cell carcinoma variants
Niki Zacharias Millward · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023 · research · R03
An actionable secretory program that drives tumor progression in a genetically defined subset of lung squamous carcinoma
Xiaochao Tan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2026 · contract · N01
FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION
Prema Robinson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · ERAnet NEURON 2
Neuropathic Pain Special Interest group (NeuPSIG) revised systematic review, meta-analysis and therapeutic guidelines
Patrick Dougherty · The University of Texas MD Anderson Cancer Center · funded by Agence Nationale de la Recherche
2023 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Simon Eschweiler · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2028 · research · R37
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM
Sangeeta Goswami · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Mechanisms of Epigenetic Plasticity in Neuropathic Pain
Shao-Rui Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
